{
    "root": "69d27397-b1ca-4f9d-9fe0-33799a88b4f2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Pirfenidone",
    "value": "20250306",
    "ingredients": [
        {
            "name": "PIRFENIDONE",
            "code": "D7NLD2JX7U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32016"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "indications": {
        "text": "pirfenidone tablets indicated treatment idiopathic pulmonary fibrosis ( ipf ) .",
        "doid_entities": [
            {
                "text": "idiopathic pulmonary fibrosis (DOID:0050156)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050156"
            },
            {
                "text": "pulmonary fibrosis (DOID:3770)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3770"
            },
            {
                "text": "ipf (DOID:2797)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2797"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 take food . \u2022 recommended : 801 mg three times daily ( 2403 mg/day ) . ( 2 ) \u2022 upon initiation treatment , titrate full 2403 mg/day 14-day period follows : treatment days days 1 7 267 mg three times daily ( 801 mg/day ) days 8 14 534 mg three times daily ( 1602 mg/day ) days 15 onward 801 mg three times daily ( 2403 mg/day ) \u2022 consider temporary reduction , treatment interruption , discontinuation management . ( 2.3 , 5.1 , 5.2 , 5.3 , 5.4 ) \u2022 prior treatment , conduct liver function tests . ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "pirfenidone tablets available 267 mg strength supplied bottles follows : 267 mg tablets : yellow , oval , biconvex , film coated tablet , debossed \u201c l \u201d one side \u201c 749 \u201d side . ndc : 72162-2465-2 : carton containing 3 bottles , containing ninety 267 mg tablets ( 270 tablets total ) store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . keep bottle tightly closed . seal bottle opening broken missing . safely throw away pirfenidone tablets date longer needed . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "none .",
    "indications_original": "Pirfenidone tablets are indicated for the treatment of idiopathic pulmonary fibrosis (IPF).",
    "contraindications_original": "\u2022\u00a0Take with food. \u2022\u00a0Recommended dosage: 801 mg three times daily (2403 mg/day). (2) \u2022\u00a0Upon initiation of treatment, titrate to the full dosage of 2403\u00a0mg/day over a 14-day period as follows: Treatment days Dosage Days 1 through 7 267 mg three times daily (801 mg/day) Days 8 through 14 534 mg three times daily (1602 mg/day) Days 15 onward 801 mg three times daily (2403 mg/day) \u2022\u00a0Consider temporary dosage reduction, treatment interruption, or \u00a0discontinuation for management of adverse reactions. (2.3, 5.1, \u00a05.2, 5.3, 5.4) \u2022\u00a0Prior to treatment, conduct liver function tests. (2.1)",
    "warningsAndPrecautions_original": "Pirfenidone tablets are available in 267 mg strength and are supplied in bottles as follows:\n                  267 mg tablets: Yellow, oval, biconvex, film coated tablet, debossed with \u201cL\u201d on one side and \u201c749\u201d on other side.\n                  NDC: 72162-2465-2:\u00a0Carton containing 3 bottles, each containing ninety 267 mg tablets (270 tablets total)\n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP Controlled Room Temperature].\n                  Keep the bottle tightly closed. Do not use if the seal over the bottle opening is broken or missing. Safely throw away any pirfenidone tablets that are out of date or no longer needed.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Pirfenidone",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32016"
        }
    ]
}